State of Wisconsin Investment Board increased its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 9.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 300,423 shares of the medical instruments supplier’s stock after purchasing an additional 25,268 shares during the quarter. State of Wisconsin Investment Board’s holdings in DENTSPLY SIRONA were worth $13,150,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of XRAY. Veritas Asset Management LLP grew its stake in shares of DENTSPLY SIRONA by 37.2% in the first quarter. Veritas Asset Management LLP now owns 8,417,655 shares of the medical instruments supplier’s stock worth $423,492,000 after purchasing an additional 2,281,200 shares during the last quarter. SG Americas Securities LLC grew its stake in shares of DENTSPLY SIRONA by 2,260.0% in the first quarter. SG Americas Securities LLC now owns 516,009 shares of the medical instruments supplier’s stock worth $25,960,000 after purchasing an additional 494,144 shares during the last quarter. Douglas Lane & Associates LLC grew its stake in shares of DENTSPLY SIRONA by 68.2% in the second quarter. Douglas Lane & Associates LLC now owns 1,061,984 shares of the medical instruments supplier’s stock worth $46,483,000 after purchasing an additional 430,599 shares during the last quarter. Champlain Investment Partners LLC grew its stake in shares of DENTSPLY SIRONA by 23.7% in the first quarter. Champlain Investment Partners LLC now owns 2,218,395 shares of the medical instruments supplier’s stock worth $111,607,000 after purchasing an additional 424,910 shares during the last quarter. Finally, Thompson Siegel & Walmsley LLC grew its stake in shares of DENTSPLY SIRONA by 26.8% in the first quarter. Thompson Siegel & Walmsley LLC now owns 1,546,691 shares of the medical instruments supplier’s stock worth $77,814,000 after purchasing an additional 326,516 shares during the last quarter. 93.80% of the stock is currently owned by institutional investors.

In other news, Director Michael J. Coleman sold 6,038 shares of the company’s stock in a transaction dated Friday, June 1st. The shares were sold at an average price of $43.97, for a total transaction of $265,490.86. Following the transaction, the director now owns 26,960 shares in the company, valued at $1,185,431.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michael C. Alfano sold 1,404 shares of the company’s stock in a transaction dated Wednesday, May 30th. The shares were sold at an average price of $45.83, for a total transaction of $64,345.32. Following the transaction, the director now owns 13,458 shares in the company, valued at approximately $616,780.14. The disclosure for this sale can be found here. 1.93% of the stock is currently owned by corporate insiders.

A number of brokerages have commented on XRAY. TheStreet cut shares of DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research report on Tuesday. ValuEngine raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research report on Monday, August 13th. Barrington Research cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 9th. Barclays cut their price target on shares of DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 8th. Finally, Jefferies Financial Group cut their price target on shares of DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday, August 8th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $52.18.

Shares of XRAY opened at $38.67 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31. The firm has a market cap of $8.68 billion, a price-to-earnings ratio of 14.54, a PEG ratio of 2.26 and a beta of 1.27. DENTSPLY SIRONA Inc has a 12 month low of $37.70 and a 12 month high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.01. The business had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.03 billion. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. During the same quarter in the prior year, the firm posted $0.65 earnings per share. sell-side analysts predict that DENTSPLY SIRONA Inc will post 2.07 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Stockholders of record on Friday, September 28th will be issued a dividend of $0.0875 per share. The ex-dividend date is Thursday, September 27th. This represents a $0.35 annualized dividend and a dividend yield of 0.91%. DENTSPLY SIRONA’s dividend payout ratio is currently 13.16%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Story: Fundamental Analysis and Choosing Stocks

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.